Market Summary
USD131.00+1.60
Market Closed1.24%
PKI Stock Price
PKI RSI Chart
PKI Valuation
PKI Price/Sales (Trailing)
PKI Profitability
PKI Fundamentals
PKI Revenue
PKI Earnings
Price Action
52 Week Range
179.58
(Low)(High)
Last 7 days
4.7%
Last 30 days
5.2%
Last 90 days
-6.6%
Trailing 12 Months
-26.6%
PKI Financial Health
PKI Investor Care
Peers (Alternatives to PerkinElmer)
View All Peers In Detail| Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|
| LARGE-CAP | ||||||||
A | 39.7B | 6.8B | -5.27% | -0.38% | 31.64 | 5.79 | 8.37% | 3.64% |
ILMN | 35.6B | 4.6B | 13.08% | -36.01% | -8.08 | 7.76 | 1.28% | -677.95% |
MTD | 33.2B | 3.9B | 4.61% | 6.69% | 38.05 | 8.47 | 5.43% | 13.46% |
WAT | 18.0B | 3.0B | -2.00% | -5.28% | 25.44 | 6.06 | 6.68% | 2.15% |
PKI | 16.5B | 3.3B | 5.16% | -26.61% | 29.07 | 5 | -34.64% | -39.65% |
| MID-CAP | ||||||||
| SMALL-CAP | ||||||||
PACB | 2.2B | 128.3M | 7.49% | 1.14% | -7.03 | 17.23 | -1.69% | -73.40% |
ADPT | 1.2B | 185.3M | -1.52% | -39.29% | -6.02 | 6.5 | 20.06% | 3.42% |
NSTG | 435.0M | 127.3M | -4.61% | -72.73% | -2.73 | 3.42 | -12.28% | -38.43% |
QTRX | 404.5M | 105.5M | -1.36% | -62.04% | -4.18 | 3.83 | -4.55% | -67.63% |
BNGO | 315.0M | 27.8M | -20.90% | -60.74% | -2.38 | 11.33 | 54.62% | -83.06% |
CDXS | 259.3M | 138.6M | -18.51% | -80.76% | -7.72 | 1.87 | 32.30% | -57.86% |
HBIO | 177.6M | 113.3M | 49.12% | -33.54% | -18.66 | 1.57 | -4.68% | -3204.17% |
PSNL | 115.8M | 65.0M | -17.61% | -70.19% | -1.02 | 1.78 | -23.92% | -73.73% |
CSBR | 55.6M | 54.1M | -11.83% | -50.42% | 514.73 | 1.03 | 21.80% | -72.38% |
Financials for PerkinElmer
| Income Statement (Last 12 Months) | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
| Revenue | -39.4% | 3,312 | 5,468 | 5,618 | 5,617 | 5,067 |
| S&GA Expenses | -29.3% | 1,026 | 1,451 | 1,486 | 1,438 | 1,228 |
| R&D Expenses | -34.6% | 222 | 339 | 335 | 327 | 275 |
| EBITDA | -22.0% | 1,079 | 1,384 | 1,340 | 1,479 | - |
| EBITDA Margin | 28.7% | 0.33* | 0.25* | 0.24* | 0.29* | - |
| Earnings Before Taxes | -27.6% | 652 | 900 | 953 | 1,055 | 1,280 |
| EBT Margin | 19.6% | 0.20* | 0.16* | 0.16* | 0.20* | - |
| Interest Expenses | - | 54.00 | - | - | - | - |
| Net Income | -9.9% | 569 | 632 | 674 | 741 | 943 |
| Net Income Margin | 48.8% | 0.17* | 0.12* | 0.12* | 0.15* | - |
| Free Cahsflow | -23.4% | 594 | 776 | 912 | 1,105 | - |
| Balance Sheet | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
| Assets | 2.2% | 14,130 | 13,824 | 14,190 | 14,848 | 15,001 |
| Current Assets | 5.5% | 3,289 | 3,116 | 2,108 | 2,455 | 2,441 |
| Cash Equivalents | 17.5% | 471 | 401 | 361 | 670 | 603 |
| Inventory | 7.2% | 405 | 378 | 624 | 646 | 426 |
| Net PPE | 4.9% | 483 | 460 | 534 | 547 | 486 |
| Goodwill | 1.7% | 6,482 | 6,373 | 7,243 | 7,367 | 6,627 |
| Liabilities | -0.2% | 6,747 | 6,759 | 7,023 | 7,662 | 7,859 |
| Current Liabilities | 4.0% | 1,544 | 1,486 | 1,044 | 1,263 | 1,214 |
| LT Debt, Current | -6.5% | 471 | 504 | 4.00 | 4.00 | 4.00 |
| LT Debt, Non Current | 0.6% | 3,923 | 3,898 | 4,484 | 4,864 | 4,980 |
| Shareholder's Equity | 4.5% | 7,383 | 7,065 | 7,167 | 7,186 | 7,141 |
| Retained Earnings | 2.4% | 4,951 | 4,834 | 4,757 | 4,585 | 4,417 |
| Additional Paid-In Capital | -0.1% | 2,753 | 2,755 | 2,743 | 2,722 | 2,761 |
| Shares Outstanding | 0.1% | 126 | 126 | 126 | 126 | 126 |
| Cashflow (Last 12 Months) | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
| Cashflow From Operations | -22.4% | 680 | 876 | 1,030 | 1,220 | 1,411 |
| Share Based Compensation | -7.7% | 52.00 | 56.00 | 52.00 | 43.00 | 33.00 |
| Cashflow From Investing | 20.5% | -132 | -167 | -3,445 | -3,707 | -4,112 |
| Cashflow From Financing | 90.0% | -661 | -6,607 | -3,786 | -3,689 | -2,941 |
| Dividend Payments | 0.0% | 35.00 | 35.00 | 34.00 | 33.00 | 32.00 |
| Buy Backs | 43.5% | 81.00 | 56.00 | 56.00 | 86.00 | 73.00 |
Risks for PKI
What is the probability of a big loss on PKI?
70.8%
Probability that PerkinElmer stock will be more than 20% underwater in next one year
32.7%
Probability that PerkinElmer stock will be more than 30% underwater in next one year.
5%
Probability that PerkinElmer stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.
How does PKI drawdown profile look like?
Y-axis is the maximum loss one would have experienced if PerkinElmer was unfortunately bought at previous high price.
Drawdowns
Returns for PKI
Cumulative Returns on PKI
15.1%
10-Year Cumulative Returns
15.3%
7-Year Cumulative Returns
11.8%
5-Year Cumulative Returns
19.8%
3-Year Cumulative Returns
What are the long-term rolling returns for PKI?
FIve years rolling returns for PerkinElmer.
Annualized Returns
Which funds bought or sold PKI recently?
View All Details| Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
|---|---|---|---|---|---|---|
2023-03-29 | Diametric Capital, LP | new | - | 1,142,230 | 1,142,230 | 0.55% |
2023-03-23 | MetLife Investment Management, LLC | reduced | -1.61 | 590,736 | 4,621,790 | 0.04% |
2023-03-17 | American Portfolios Advisors | reduced | -1.94 | -21,198 | 103,245 | -% |
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | added | 19.34 | 2,610,010 | 9,289,010 | 0.01% |
2023-03-10 | MATHER GROUP, LLC. | new | - | 247,068 | 247,068 | -% |
2023-03-06 | Rockefeller Capital Management L.P. | added | 0.98 | 806,000 | 5,365,000 | 0.03% |
2023-03-03 | TIAA, FSB | added | 0.14 | 102,329 | 719,329 | -% |
2023-03-02 | LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA | new | - | 42,066 | 42,066 | -% |
2023-02-28 | Voya Investment Management LLC | added | 2.48 | 1,016,470 | 6,249,470 | 0.01% |
2023-02-24 | Palmer Knight Co | reduced | -0.04 | 676,100 | 4,780,100 | 4.27% |
Latest Funds Activity
Calls
Puts
Net Call Options
No. of Funds
PerkinElmer News
Schedule 13G FIlings of PerkinElmer
| Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
|---|---|---|---|---|---|
| Feb 14, 2023 | t. rowe price investment management, inc. | 7.4% | 9,398,370 | SC 13G/A | |
| Feb 14, 2023 | select equity group, l.p. | 7.7% | 9,777,698 | SC 13G/A | |
| Feb 13, 2023 | capital research global investors | 10.2% | 12,860,903 | SC 13G/A | |
| Feb 09, 2023 | vanguard group inc | 11.40% | 14,393,876 | SC 13G/A | |
| Feb 01, 2023 | blackrock inc. | 6.7% | 8,473,845 | SC 13G/A | |
| Feb 14, 2022 | select equity group, l.p. | 4.93% | 6,222,710 | SC 13G/A | |
| Feb 11, 2022 | capital research global investors | 10.4% | 13,082,180 | SC 13G/A | |
| Feb 10, 2022 | vanguard group inc | 10.92% | 13,785,723 | SC 13G/A | |
| Feb 10, 2022 | price t rowe associates inc /md/ | 11.3% | 14,360,428 | SC 13G/A | |
| Feb 10, 2022 | price t rowe associates inc /md/ | 7.9% | 10,056,779 | SC 13G |
PKI Fair Value
PerkinElmer fair value in different scenarios
The table shows the Fair Value estimates for PerkinElmer for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
| Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
|---|---|---|---|---|---|
| Very Low Inflation | 75.07 -42.69% | 92.41 -29.46% | 124.64 -4.85% | 207.60 58.47% | 310.93 137.35% |
| Current Inflation | 69.92 -46.63% | 84.78 -35.28% | 111.89 -14.59% | 181.84 38.81% | 268.69 105.11% |
| Very High Inflation | 63.54 -51.50% | 75.53 -42.34% | 96.81 -26.10% | 152.06 16.08% | 220.36 68.21% |
Historical PerkinElmer Fair Value Estimates
Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price
Recent SEC filings of PerkinElmer
View All Filings| Date Filed | Form Type | Document | |
|---|---|---|---|
| Mar 29, 2023 | 144 | Notice of Insider Sale Intent | |
| Mar 22, 2023 | 4 | Insider Trading | |
| Mar 20, 2023 | 144 | Notice of Insider Sale Intent | |
| Mar 17, 2023 | 4 | Insider Trading | |
| Mar 16, 2023 | 8-K | Current Report | |
| Mar 08, 2023 | DEFA14A | DEFA14A | |
| Mar 08, 2023 | DEF 14A | DEF 14A | |
| Mar 08, 2023 | ARS | ARS | |
| Mar 01, 2023 | 10-K | Annual Report | |
| Feb 21, 2023 | 4 | Insider Trading |
Latest Insider Trading transactions for PKI
Filter Transactions| Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
|---|---|---|---|---|---|---|
2023-03-20 | Tereau Daniel R | acquired | 197,438 | 52.65 | 3,750 | please see remarks |
2023-03-20 | Tereau Daniel R | sold | -1,328,910 | 123 | -10,741 | please see remarks |
2023-03-16 | Krakowiak Maxwell | sold (taxes) | -2,573 | 122 | -21.00 | please see remarks |
2023-02-16 | Vohra Tajinder S | acquired | - | - | 2,201 | please see remarks |
2023-02-16 | Krakowiak Maxwell | acquired | - | - | 4,877 | please see remarks |
2023-02-16 | Goldberg Joel S | acquired | - | - | 3,568 | please see remarks |
2023-02-16 | Singh Prahlad R. | acquired | - | - | 14,272 | please see remarks |
2023-02-16 | Okun Andrew | acquired | - | - | 3,715 | please see remarks |
2023-02-16 | Victor Miriame | acquired | - | - | 2,132 | please see remarks |
2023-02-16 | Tereau Daniel R | acquired | - | - | 1,438 | please see remarks |
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
PKI Income Statement
2023-01-01Consolidated Statements of Operations - USD ($) $ in Thousands | 12 Months Ended | ||
|---|---|---|---|
Jan. 01, 2023 | Jan. 02, 2022 | Jan. 03, 2021 | |
| Revenue | |||
| Revenue from Contract with Customer, Excluding Assessed Tax | $ 3,311,822 | $ 3,827,808 | $ 2,663,230 |
| Selling, general and administrative expenses | 1,025,514 | 975,193 | 716,465 |
| Research and development expenses | 221,617 | 200,337 | 146,441 |
| Restructuring and other costs, net | (13,580) | 14,358 | 7,661 |
| Operating income from continuing operations | 742,699 | 1,258,457 | 867,273 |
| Interest and other expense, net | 90,862 | 54,875 | 67,201 |
| Income from continuing operations before income taxes | 651,837 | 1,203,582 | |
| Income from continuing operations before income taxes | 651,837 | 1,203,582 | 800,072 |
| Provision for income taxes | 139,161 | 314,146 | 169,512 |
| Income from continuing operations | 512,676 | 889,436 | 630,560 |
| Income from discontinued operations before income taxes | 73,604 | 76,304 | 106,292 |
| (Loss) gain on disposition of discontinued operations before income taxes | 0 | 0 | (76) |
| (Benefit from) provision for income taxes on discontinued operations and dispositions | 17,101 | 22,583 | 8,889 |
| Income from discontinued operations and dispositions | 56,503 | 53,721 | 97,327 |
| Net income | $ 569,179 | $ 943,157 | $ 727,887 |
| Basic earnings per share: | |||
| Income from continuing operations | $ 4.06 | $ 7.66 | $ 5.65 |
| Income from discontinued operations and dispositions | 0.45 | 0.46 | 0.87 |
| Net income | 4.51 | 8.12 | 6.52 |
| Diluted earnings per share: | |||
| Income from continuing operations | 4.06 | 7.62 | 5.63 |
| Income from discontinued operations and dispositions | 0.45 | 0.46 | 0.87 |
| Net income | $ 4.50 | $ 8.08 | $ 6.49 |
| Product [Member] | |||
| Revenue | |||
| Revenue from Contract with Customer, Excluding Assessed Tax | $ 2,634,582 | $ 2,735,068 | $ 2,280,853 |
| Cost of Goods and Services Sold | 1,150,402 | 1,129,223 | 794,405 |
| Service [Member] | |||
| Revenue | |||
| Revenue from Contract with Customer, Excluding Assessed Tax | 677,240 | 1,092,740 | 382,377 |
| Cost of Goods and Services Sold | $ 171,590 | $ 264,598 | $ 138,646 |
PKI Balance Sheet
2023-01-01Consolidated Balance Sheets - USD ($) $ in Thousands | Jan. 01, 2023 | Jan. 02, 2022 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $ 454,358 | $ 603,320 |
| Accounts receivable, net | 612,780 | 707,941 |
| Inventories | 405,462 | 425,890 |
| Other current assets | 122,254 | 148,255 |
| Current assets of discontinued operations | 1,693,704 | 555,374 |
| Total current assets | 3,288,558 | 2,440,780 |
| Property, plant and equipment, net | 482,950 | 485,531 |
| Operating Lease, Right-of-Use Asset | 188,351 | 164,040 |
| Intangible assets, net | 3,377,174 | 3,821,847 |
| Goodwill | 6,481,768 | 6,627,119 |
| Other assets, net | 311,054 | 317,069 |
| Long-term assets of discontinued operations | 0 | 1,144,168 |
| Total assets | 14,129,855 | 15,000,554 |
| Current liabilities: | ||
| Current portion of long-term debt | 470,929 | 4,240 |
| Accounts payable | 272,826 | 324,811 |
| Accrued expenses and other current liabilities | 527,863 | 679,099 |
| Current liabilities of discontinued operations | 272,865 | 205,594 |
| Total current liabilities | 1,544,483 | 1,213,744 |
| Long-term debt | 3,923,347 | 4,979,737 |
| Long-term liabilities | 1,109,181 | 1,426,731 |
| Operating Lease, Liability, Noncurrent | 169,968 | 147,395 |
| Long-term liabilities of discontinued operations | 0 | 91,702 |
| Total liabilities | 6,746,979 | 7,859,309 |
| Commitments and contingencies (see Note 16) | ||
| Stockholders' equity: | ||
| Preferred stock—$1 par value per share, authorized 1,000,000 shares; none issued or outstanding | 0 | 0 |
| Common stock—$1 par value per share, authorized 300,000,000 shares; issued and outstanding 126,300,000 and 126,241,000 shares at January 1, 2023 and January 2, 2022, respectively | 126,300 | 126,241 |
| Capital in excess of par value | 2,753,055 | 2,760,522 |
| Retained earnings | 4,951,018 | 4,417,174 |
| Accumulated other comprehensive loss | (447,497) | (162,692) |
| Total stockholders' equity | 7,382,876 | 7,141,245 |
| Total liabilities and stockholders' equity | $ 14,129,855 | $ 15,000,554 |